| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/30/1992 | US5126326 Enzyme inhibiting peptide derivatives |
| 06/30/1992 | US5126325 Method for treating thrombocytopenia |
| 06/30/1992 | US5126324 Method of enhancing growth in patients using combination therapy |
| 06/30/1992 | US5126323 Homogeneous purified k-fgf and compositions containing the same |
| 06/30/1992 | US5126322 Pancreatic secretory tryspin inhibitor and variants thereof produced by a recombinant host therefore and pharmaceutical use thereof |
| 06/30/1992 | US5126257 Antimicrobial proteins, compositions containing same and uses thereof |
| 06/30/1992 | US5126252 Production of bovine and porcine growth hormones |
| 06/30/1992 | US5126249 Enzymatic removal of a protein amino-terminal sequence |
| 06/30/1992 | US5126148 Produced by human hematopoietic cells |
| 06/30/1992 | US5126134 Pharmaceutically active combination |
| 06/30/1992 | US5126132 Tumor infiltrating lymphocytes as a treatment modality for human cancer |
| 06/30/1992 | US5126129 Administering synergistic combination |
| 06/30/1992 | CA1304288C Cell-free t cell antigen receptor and its clinical utilities |
| 06/29/1992 | WO1992012178A1 Protein with human choriogonadotropin inhibitory effect |
| 06/29/1992 | WO1992012177A1 Novel megakaryocyte amplifier and production thereof |
| 06/29/1992 | WO1992012140A1 Peptides ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | WO1992011850A2 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| 06/29/1992 | CA2098702A1 Peptide ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | CA2098609A1 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
| 06/29/1992 | CA2075981A1 Protein with human choriogonadotropin inhibitory effect |
| 06/29/1992 | CA2073177A1 Megakaryocyte potentiator and method for producing the same |
| 06/29/1992 | CA2058351A1 Avian growth hormone receptor and binding protein |
| 06/28/1992 | WO1992012171A1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 06/28/1992 | WO1992012168A1 Modified hexa- and heptapeptide anaphylatoxin receptor ligands |
| 06/28/1992 | WO1992011858A1 Hexa- and heptapeptide anaphylatoxin-receptor ligands |
| 06/28/1992 | CA2095360A1 Modified hexa- and heptapeptide anaphylatoxin receptor ligands |
| 06/28/1992 | CA2095359A1 Hexa- and heptapeptide anaphylatoxin receptor ligands |
| 06/28/1992 | CA2076877A1 Synthetic peptides with immunomodulating activity and their preparation |
| 06/28/1992 | CA2058003A1 Human-interleukin-5 receptor |
| 06/25/1992 | WO1992010756A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
| 06/25/1992 | WO1992010755A1 Proteins with changed epitopes and methods for the production thereof |
| 06/25/1992 | WO1992010747A1 Container system for storage stable pharmaceuticals |
| 06/25/1992 | WO1992010583A1 G protein-coupled glutamate receptors |
| 06/25/1992 | WO1992010574A1 Inhibition of human immunodeficiency virus by an adeno-associated virus gene for human cells |
| 06/25/1992 | WO1992010573A1 Methods and compositions for the suppression of neu mediated transformation |
| 06/25/1992 | WO1992010569A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine |
| 06/25/1992 | WO1992010567A1 Synthetic bioadhesive polypeptide |
| 06/25/1992 | WO1992010520A1 Monoclonal antibody op-g2 and method of use |
| 06/25/1992 | WO1992010518A1 Purified slit protein and sequence elements thereof |
| 06/25/1992 | WO1992010517A1 Tetrapeptides deriving from dalbaheptide antibiotics |
| 06/25/1992 | WO1992010515A1 Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance |
| 06/25/1992 | WO1992010512A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 06/25/1992 | WO1992010511A1 Compounds and compositions which inhibit bone resorption |
| 06/25/1992 | WO1992010510A1 Dithiolano- and dithianoglycin-containing renin-inhibiting peptides, process for producing the same and their use in medicaments |
| 06/25/1992 | WO1992010509A1 Renin-inhibiting peptides of the cyclohexylstatin type, process for producing the same and their use in medicaments |
| 06/25/1992 | WO1992010210A1 Inhibition of angiogenesis by il-1 |
| 06/25/1992 | WO1992010206A1 Use of plasminogen activator inhibitor type 2 in the treatment of cancer |
| 06/25/1992 | WO1992010200A1 Functional interactions between glial s-100b and central nervous system serotonergic neurons |
| 06/25/1992 | WO1992010197A1 Substances of polypeptide nature useful in human therapy |
| 06/25/1992 | WO1992010164A1 Agent for reducing the growth of, or removing, human body hair |
| 06/25/1992 | WO1992010097A1 Angiotensin ii receptor blocking compositions |
| 06/25/1992 | WO1992008731A3 T-cadherin adhesion molecule |
| 06/25/1992 | WO1992008474A3 Treatment of lung diseases |
| 06/25/1992 | WO1992006992A3 New process for biophosphorylating organic compounds |
| 06/25/1992 | DE4042008A1 Vasopressin-derivate Vasopressin derivatives |
| 06/25/1992 | DE4041570A1 New conjugates of ancrod and polyalkylene glycols - for treatment of Myocardial infarction, stroke, thrombosis etc., have longer half-life than ancrod alone |
| 06/25/1992 | DE4041464A1 5-ht(pfeil abwaerts)1(pfeil abwaerts)-rezeptor 5-ht (Down Arrow) 1 (down arrow) receptor |
| 06/25/1992 | DE4041189A1 New peptides as TNF agonists and antagonists - for treatment of neoplastic and auto:immune disease, infection, inflammation and transplant rejection |
| 06/25/1992 | DE4041188A1 New peptide(s) of TNF agonists and antagonists - used for treating neoplastic and autoimmune disease, infection, inflammation and transplant rejection |
| 06/25/1992 | DE4041187A1 Neue tnf-peptide New tnf-peptide |
| 06/25/1992 | DE4041185A1 Verwendung von hirudin und dessen muteinen zur kombinationsbehandlung von tumoren Use of hirudin and its muteins for combination treatment of tumors |
| 06/25/1992 | DE4041059A1 New peptide for treating arthritis - contg. aminoacid sequence comprising epitope of fragment from human collagen |
| 06/25/1992 | CA2098188A1 Sperm cell surface protein ph-20 use in a contraceptive vaccine |
| 06/25/1992 | CA2097935A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
| 06/25/1992 | CA2058079A1 Method of treating thromboembolic disorders |
| 06/25/1992 | CA2057675A1 Peptide inhibitors of ras-gap interaction |
| 06/25/1992 | CA2056118A1 Monoclonal antibodies which bind mannose binding protein |
| 06/24/1992 | EP0491675A1 Improvements relating to growth factors |
| 06/24/1992 | EP0491628A2 Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines |
| 06/24/1992 | EP0491361A2 Short peptides having the effect of insulin |
| 06/24/1992 | EP0491351A2 Chimeric antibodies and their use |
| 06/24/1992 | EP0491218A1 Benzodiazepinones |
| 06/24/1992 | EP0491114A1 A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity |
| 06/24/1992 | EP0491077A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 06/24/1992 | EP0491061A1 Use of enalapril and perindopril as prolactin-lowering medicament |
| 06/24/1992 | EP0491032A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
| 06/24/1992 | EP0491018A1 Use of taurolidine and/or taurultam for the treatment of tumours |
| 06/24/1992 | EP0490975A1 Interleukin-4 receptors |
| 06/24/1992 | EP0490947A1 Prodrug derivatives of thyrotropin-releasing hormone (trh) |
| 06/24/1992 | EP0462207A4 Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression |
| 06/24/1992 | CN1062172A Ribosome-inactivating proteins, inactive precursor forms thereof, process for making and method of using |
| 06/24/1992 | CN1062146A Muramyldipeptide derivatives and influenza vaccine comprising derivatives |
| 06/23/1992 | WO1992011362A1 Serotonine receptor of class 1: the 5-ht1x receptors |
| 06/23/1992 | US5124471 Radiolabeling proteins |
| 06/23/1992 | US5124440 Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus |
| 06/23/1992 | US5124437 High-molecular-weight missile drug carriers |
| 06/23/1992 | US5124392 Administering a steroid |
| 06/23/1992 | US5124322 Antiarthritic agents |
| 06/23/1992 | US5124316 Applying growth promoting amount of polypeptide growth factor |
| 06/23/1992 | US5124315 Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient |
| 06/23/1992 | US5124314 Treatment of diabetes or hypoglycemia |
| 06/23/1992 | US5124313 Applying extract of yellow or deep green vegetables which contains retinyl fatty acid ester complexed with polypeptide, isoprenoid |
| 06/23/1992 | US5124156 Lysozyme of egg white and mace extract |
| 06/23/1992 | US5124154 Aminosteroids for ophthalmic use |
| 06/23/1992 | US5124146 Differential delivery of therapeutic agents across the blood brain barrier |
| 06/23/1992 | US5124145 Method for the prevention and treatment of bovine mastitis |
| 06/23/1992 | CA2098706A1 5-ht1x receptor |
| 06/23/1992 | CA1304193C Grf analogs v |
| 06/23/1992 | CA1304192C Grf analogs vi |
| 06/23/1992 | CA1304024C Covalently linked polypeptide cell modulators |